Literature DB >> 22855419

Bile aspiration and hydrodissection to prevent complications in hepatic RFA close to the gallbladder.

Elena Levit1, Philipp Bruners, Rolf W Günther, Andreas H Mahnken.   

Abstract

BACKGROUND: Radiofrequency ablation (RFA) of liver tumors is a mainstay of interventional oncology. Its application, however, is limited by tumor size and location with lesions located within 1 cm to the gallbladder being at increased risk for complications.
PURPOSE: To evaluate the safety of hepatic RFA after bile aspiration with or without additional hydrodissection for lesions adjacent to the gallbladder.
MATERIAL AND METHODS: Six patients undergoing RFA of tumors with a distance of less than 1 cm to the gallbladder were retrospectively identified from a computer database. All patients underwent RFA combined with percutaneous bile aspiration from the gallbladder. In four patients additional hydrodissection was performed. Technical success and post-interventional complications were assessed by reviewing images and patient charts.
RESULTS: Ablations were successfully completed in 5/6 patients. In one patient with incomplete ablation re-ablation was performed 2 months after the initial procedure. Minor complications occurred in three patients, including right-sided pleural effusion, hematoma in the gallbladder fossa, and intralesional hemorrhage in one patient each. There were no cases with cholecystitis or damage to the gallbladder during follow-up.
CONCLUSION: Bile aspiration with or without additional hydrodissection permits safe RFA of tumors located close to the gallbladder.

Entities:  

Mesh:

Year:  2012        PMID: 22855419     DOI: 10.1258/ar.2012.120190

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  7 in total

Review 1.  Update on treatment of liver metastases: focus on ablation therapies.

Authors:  Jeffrey Meyer; Seth Toomay
Journal:  Curr Oncol Rep       Date:  2015-01       Impact factor: 5.075

Review 2.  Image-guided percutaneous ablation of hepatic malignancies.

Authors:  Gretchen Foltz
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

3.  Efficacy and Safety of Angioplasty Balloon Interposition in CT-Guided Percutaneous Thermal Ablation of Hepatic Malignancies to Protect Adjacent Organs.

Authors:  Michael Schlappa; Wolfgang Wüst; Jürgen Siebler; Robert Grützmann; Michael Uder; Axel Schmid
Journal:  Cardiovasc Intervent Radiol       Date:  2022-07-06       Impact factor: 2.797

Review 4.  Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation Criteria.

Authors:  Yanzhao Zhou; Yi Yang; Bingyan Zhou; Zhengzheng Wang; Ruili Zhu; Xun Chen; Jingzhong Ouyang; Qingjun Li; Jinxue Zhou
Journal:  J Hepatocell Carcinoma       Date:  2021-06-21

5.  Radiofrequency thermoablation of HCC larger than 3 cm and less than 5 cm proximal to the gallbladder without gallbladder isolation: a single center experience.

Authors:  Antonio Orlacchio; Fabrizio Chegai; Costantino Del Giudice; Mariangela Massaccesi; Elisa Costanzo; Elena Di Caprera; Giovanni Simonetti
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

Review 6.  Thyroid Radiofrequency Ablation: Updates on Innovative Devices and Techniques.

Authors:  Hye Sun Park; Jung Hwan Baek; Auh Whan Park; Sae Rom Chung; Young Jun Choi; Jeong Hyun Lee
Journal:  Korean J Radiol       Date:  2017-05-19       Impact factor: 3.500

7.  CT-guided microwave ablation through the lungs for treating liver tumors near the diaphragm.

Authors:  Han Qi; Hao Zhang; Chao Wan; Lin Xie; Ze Song; Weijun Fan
Journal:  Oncotarget       Date:  2017-04-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.